Year | Title | Author(s) |
2012 |
Genetically engineered mouse models and human osteosarcoma
Clin Sarcoma Res |
Baker, EK Mutsaers, AJ Ng, AJM Walkley, CR |
2013 |
Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA
Bone |
Mutsaers, AJ Ng, AJM Baker, EK Russell, MR Chalk, AM Wall, M Liddicoat, BJJ Ho, PWM Slavin, JL Goradia, A Martin, TJ Purton, LE Dickins, RA Walkley, CR |
2014 |
Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?
Bone |
Mutsaers, AJ Walkley, CR |
2015 |
The DNA Helicase Recql4 Is Required for Normal Osteoblast Expansion and Osteosarcoma Formation
Plos Genetics |
Ng, AJM Walia, MK Smeets, MF Mutsaers, AJ Sims, NA Purton, LE Walsh, NC Martin, TJ Walkley, CR |
2015 |
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Clin. Cancer Res. |
Gupte, A Baker, EK Wan, SS Stewart, E Loh, A Shelat, AA Gould, CM Chalk, AM Taylor, S Lackovic, K Karlstrom, A Mutsaers, AJ Desai, J Madhamshettiwar, PB Zannettino, ACW Burns, C Huang, DCS Dyer, MA Simpson, KJ Walkley, CR |
2015 |
Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research |
Gupte, A Baker, EK Wan, SS Stewart, E Loh, A Shelat, AA Gould, CM Chalk, AM Taylor, S Lackovic, K Karlstrom, A Mutsaers, AJ Desai, J Madhamshettiwar, PB Zannettino, AC Burns, C Huang, DC Dyer, MA Simpson, KJ Walkley, CR |
2018 |
Murine models of osteosarcoma: A piece of the translational puzzle
J. Cell. Biochem. |
Walia, MK Castillo-Tandazo, W Mutsaers, AJ Martin, TJ Walkley, CR |
2019 |
Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets
Current Osteoporosis Reports |
Castillo-Tandazo, W Mutsaers, AJ Walkley, CR |